AU6046696A - Peptides and compounds that bind to a receptor - Google Patents

Peptides and compounds that bind to a receptor

Info

Publication number
AU6046696A
AU6046696A AU60466/96A AU6046696A AU6046696A AU 6046696 A AU6046696 A AU 6046696A AU 60466/96 A AU60466/96 A AU 60466/96A AU 6046696 A AU6046696 A AU 6046696A AU 6046696 A AU6046696 A AU 6046696A
Authority
AU
Australia
Prior art keywords
peptides
bind
receptor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60466/96A
Other languages
English (en)
Inventor
Ronald W. Barrett
Steven E. Cwirla
William J. Dower
David J. Duffin
Christian M. Gates
Sherril S. Johnson
Larry C Mattheakis
Peter J Schatz
Christopher R. Wagstrom
Nicholas C. Wrighton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU6046696A publication Critical patent/AU6046696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU60466/96A 1995-06-07 1996-06-05 Peptides and compounds that bind to a receptor Abandoned AU6046696A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US47616895A 1995-06-07 1995-06-07
US48409095A 1995-06-07 1995-06-07
US47237195A 1995-06-07 1995-06-07
US47360495A 1995-06-07 1995-06-07
US47812895A 1995-06-07 1995-06-07
US48530195A 1995-06-07 1995-06-07
US473604 1995-06-07
US484090 1995-06-07
US478128 1995-06-07
US472371 1995-06-07
US476168 1995-06-07
US485301 1995-06-07
PCT/US1996/008998 WO1996040189A1 (fr) 1995-06-07 1996-06-05 Peptides et composes se fixant a un recepteur

Publications (1)

Publication Number Publication Date
AU6046696A true AU6046696A (en) 1996-12-30

Family

ID=27560032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60466/96A Abandoned AU6046696A (en) 1995-06-07 1996-06-05 Peptides and compounds that bind to a receptor

Country Status (5)

Country Link
AU (1) AU6046696A (fr)
HR (1) HRP960256A2 (fr)
MY (1) MY113497A (fr)
WO (1) WO1996040189A1 (fr)
YU (1) YU34196A (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
CN101284865A (zh) 1998-11-05 2008-10-15 富山化学工业株式会社 新型化合物及其医药用途
AU1764200A (en) * 1998-12-18 2000-07-12 Mount Sinai Hospital Corporation Three dimensional structure of a sterile alpha motif domain
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
WO2001010891A2 (fr) 1999-08-05 2001-02-15 Research Corporation Technologies, Inc. Antagonistes d'il-16
EP1149906A1 (fr) * 2000-04-25 2001-10-31 Pliva, Farmaceutska, Industrija, Dionicko Drustvo Peptide modulateur du récepteur de la thrombopoietine
EP1282437B1 (fr) 2000-05-16 2008-03-19 Genentech, Inc. Traitement des lesions du cartilage
US7396917B2 (en) 2000-12-05 2008-07-08 Alexion Pharmaceuticals, Inc. Rationally designed antibodies
EP1642910B1 (fr) * 2000-12-05 2012-02-08 Alexion Pharmaceuticals, Inc. Anticorps conçus de manière rationnelle
WO2002076173A2 (fr) * 2001-03-21 2002-10-03 The University Of Texas System Inhibiteurs de glycosaminoglycanes
US7332474B2 (en) 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
US7851503B2 (en) 2002-08-14 2010-12-14 Nissan Chemical Industries, Ltd. Thrombopoetin receptor activator and process for producing the same
PT1542714E (pt) 2002-09-18 2014-06-23 Janssen Pharmaceuticals Inc Métodos para aumentar a produção de células estaminais plaquetárias e hematopoiéticas
TWI324593B (en) 2002-10-09 2010-05-11 Nissan Chemical Ind Ltd Pyrazolone compounds and thrombopoietin receptor activator
MXPA05012313A (es) 2003-05-12 2006-04-18 Affymax Inc Peptidos que se unen al receptor de eritropoyetina.
US7919118B2 (en) 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds
KR101163683B1 (ko) 2003-05-12 2012-07-10 아피맥스, 인크. 에리스로포이에틴 수용체에 결합하는 신규의 펩티드
EP1819692A1 (fr) 2004-12-08 2007-08-22 Nissan Chemical Industries, Ltd. Composes heterocycliques a substitution 3-ethylidenehydrazino utilises en tant qu'activateurs du recepteur de la thrombopoietine
EP1845090A4 (fr) 2004-12-14 2009-11-11 Nissan Chemical Ind Ltd Compose d' amide et activateur du recepteur de la thrombopoietine
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
AU2006270801B2 (en) 2005-07-15 2011-12-22 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
WO2007011056A1 (fr) 2005-07-20 2007-01-25 Nissan Chemical Industries, Ltd. Composes de pyrazole et activateurs du recepteur de la thrombopoietine
JP5205967B2 (ja) 2005-11-07 2013-06-05 日産化学工業株式会社 ヒドラジド化合物及びトロンボポエチンレセプター活性化剤
WO2007142308A1 (fr) 2006-06-07 2007-12-13 Nissan Chemical Industries, Ltd. Composé hétérocyclique azoté et activateur de récepteur de thrombopoïétine
US7981425B2 (en) 2006-06-19 2011-07-19 Amgen Inc. Thrombopoietic compounds
EP1897888A1 (fr) * 2006-09-05 2008-03-12 AplaGen GmbH Peptides se liant au récepteur TPO
WO2008028645A1 (fr) * 2006-09-05 2008-03-13 Aplagen Gmbh Peptides se liant au récepteur de tpo
JP2010520855A (ja) 2007-01-31 2010-06-17 アフィーマックス・インコーポレイテッド 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー
WO2009029682A1 (fr) * 2007-08-28 2009-03-05 Rigel Pharmaceuticals, Inc. Thérapie de combinaison avec un inhibiteur de la kinase syk
EP2492262B1 (fr) 2009-10-23 2016-04-20 Nissan Chemical Industries, Ltd. Composés hétérocycles fusionnés et activateur du récepteur de la thrombopoïétine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198424A (en) * 1989-03-08 1993-03-30 Board Of Regents Of The University Of Oklahoma Functionally active selectin-derived peptides

Also Published As

Publication number Publication date
YU34196A (sh) 1999-03-04
WO1996040189A1 (fr) 1996-12-19
MY113497A (en) 2002-03-30
HRP960256A2 (en) 1998-02-28

Similar Documents

Publication Publication Date Title
AU6046696A (en) Peptides and compounds that bind to a receptor
ZA964814B (en) Peptides and compounds that bind to a receptor.
HRP970683B1 (en) Peptides and compounds that bind to a receptor
AU1872595A (en) Peptides and compounds that bind to the il-1 receptor
AU5396496A (en) A vibrator
AU5772996A (en) Composite materials
AU4972096A (en) Peptides and compounds that bind to sh2 domains
AU699201B2 (en) Highly fluidized concrete composition
AU4394396A (en) Modified peptides
AU6748196A (en) Receptor
AU698277B2 (en) Particulate materials
AU7919498A (en) Peptides and compounds that bind to the il-5 receptor
AU5161296A (en) Anti-haemorrhagic peptides
AU4728196A (en) Specific binding materials
AU6748096A (en) A composite material
AU2003200384A1 (en) Peptides and compounds that bind to the IL-5 receptor
AU2003200308A1 (en) Peptides and compounds that bind to the IL-5 receptor
IL112533A0 (en) Composite materials
EP0765906A3 (fr) Matériaux composites ignifugés
GB9713952D0 (en) Specific binding materials
AU692350B2 (en) A transporter
AUPN323295A0 (en) Roofing materials
AUPN250595A0 (en) Bale transporter
AUPN675495A0 (en) Bale transporter
GB9512756D0 (en) Composite materials